MediFind

Find a Doctor

Daisuke Sakai

Tokai University School Of Medicine
Male

Bio


Daisuke Sakai is in Suita, Japan. They have been an author on 246 peer reviewed articles in the past 15 years. Dr. Sakai's top three areas of expertise are Treacher Collins Syndrome, Herniated Disk, and Acrofrontofacionasal Dysostosis Syndrome.

Contact

Suita, JP

Latest Research


Latest Advance
Study
  • Condition: HER2-Positive Gastric Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Trastuzumab Deruxtecan
  • Number of Patients: 187
  • Published —
The study researched the safety and effectiveness of Trastuzumab Deruxtecan in treating HER2-positive gastric cancer.
Latest Advance
Study
  • Condition: Clinical SS/SE N1-3 M0 Gastric Cancer (GC)
  • Journal: The oncologist
  • Treatment Used: Peri-Operative Capecitabine plus Oxaliplatin (CapeOx) Therapy
  • Number of Patients: 37
  • Published —
This study examined the effectiveness of perioperative capecitabine and oxaliplatin (CapeOx) in patients with gastric cancer (GC).
Latest Advance
Study
  • Condition: Advanced Esophageal Squamous Cell Carcinoma
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: S-1, Oxaliplatin and Leucovorin
  • Number of Patients: 10
  • Published —
The study measured using a combination of S-1, Oxaliplatin and Leucovorin to treat advanced esophageal squamous cell carcinoma.
Latest Advance
Study
  • Condition: Pancreatic Ductal Adenocarcinoma (PDAC)
  • Journal: Annals of surgical oncology
  • Treatment Used: Gemcitabine, S-1, and Radiation Therapy
  • Number of Patients: 57
  • Published —
In this study, researchers evaluated the effectiveness of treating pancreatic ductal adenocarcinoma (PDAC) with the combination of gemcitabin, S-1, and radiation therapy.
Latest Advance
Study
  • Condition: Adult Spinal Deformity
  • Journal: Scientific reports
  • Treatment Used: eXtreme Lateral Interbody Fusion
  • Number of Patients: 38
  • Published —
The study researched using eXtreme lateral interbody fusion (going through the side for repairing the spine) on adult spinal deformities.
Latest Advance
Study
  • Condition: Locally Advanced Rectal Cancer
  • Journal: Oncology
  • Treatment Used: Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI)
  • Number of Patients: 6
  • Published —
This study determined the recommended dose (RD) of capecitabine combined with oxaliplatin and irinotecan (XELOXIRI) as a neoadjuvant chemotherapy in patients with locally advanced rectal cancer.
Latest Advance
Study
  • Condition: Gastric cancer
  • Journal: Anticancer research
  • Treatment Used: Trastuzumab with S-1 plus cisplatin
  • Number of Patients: 15
  • Published —
This study evaluated the efficacy and safety of transtuzumab with S-1 plus cisplatin in HER2-positive advanced gastric cancer without measurable lesions.
Latest Advance
Study
  • Condition: Metastatic colorectal cancer
  • Journal: Cancer science
  • Treatment Used: Aflibercept plus 5-fluorouracil/levofolinate/irinotecan (FOLFIRI)
  • Number of Patients: 60
  • Published —
This study assessed the efficacy and safety of aflibercept plus 5-fluorouracil/levofolinate/irinotecan (FOLFIRI) as a second-line treatment for metastatic colorectal cancer.
Latest Advance
Study
  • Condition: Biliary Tract Cancer
  • Journal: Annals of surgery
  • Treatment Used: Adjuvant Gemcitabine or S-1 Chemotherapy
  • Number of Patients: 0
  • Published —
This study compared the clinical outcome of using adjuvant gemcitabine or S-1 chemotherapy to treat patients with biliary tract cancer.
Latest Advance
Study
  • Condition: Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer (AGC)
  • Journal: The oncologist
  • Treatment Used: Capecitabine-Cisplatin Every 3 Weeks vs. S-1-Cisplatin Every 5 Weeks
  • Number of Patients: 84
  • Published —
This study evaluated the safety and effectiveness of capecitabine plus cisplatin in comparison with S-1 plus cisplatin for first-line treatment of human epidermal growth receptor 2 (HER2)-negative advanced gastric cancer in Japan.
Latest Advance
Study
  • Condition: Gastric cancer
  • Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
  • Treatment Used: Chemotherapy with S-1 alone versus S-1 plus cisplatin
  • Number of Patients: 444
  • Published —
This study evaluated first-line chemotherapy with S-1 alone versus with S-1 plus cisplatin for elderly patients with advanced gastric cancer.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
  • Published —
Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3).

Contact

Suita, JP

Insurance

Contact them to find out if they accept your insurance plan.